161 related articles for article (PubMed ID: 15297236)
1. [Analytic study of dot blotting for the detection of anti-Jo-1, anti-M2, anti-ribosomes and anti-LKM].
Huguet S; Sghiri R; Ballot E; Johanet C
Ann Biol Clin (Paris); 2004; 62(4):423-9. PubMed ID: 15297236
[TBL] [Abstract][Full Text] [Related]
2. [Analysis of dot-blot technique for the detection of three autoantibodies (anti-Jo-1, anti-M2, anti-ribosome). Comparison with reference techniques].
Roussel B; Dubel L; Kantara-Doukoure M; Bernard M; Johanet C
Ann Biol Clin (Paris); 1995; 53(9):487-90. PubMed ID: 8830560
[TBL] [Abstract][Full Text] [Related]
3. Diagnostic accuracy of four different immunological methods for the detection of anti-F-actin autoantibodies in type 1 autoimmune hepatitis and other liver-related disorders.
Villalta D; Bizzaro N; Da Re M; Tozzoli R; Komorowski L; Tonutti E
Autoimmunity; 2008 Feb; 41(1):105-10. PubMed ID: 18176872
[TBL] [Abstract][Full Text] [Related]
4. [Characterization of anti-mitochondrial antibodies type 2 (anti-M2): comparison of two techniques, western blotting and indirect immunofluorescence].
Soulié E; Moulin V; Fourel V; Dubel L; Kantara-Doukoure M; Johanet C
Ann Biol Clin (Paris); 1993; 51(7-8):707-11. PubMed ID: 8166387
[TBL] [Abstract][Full Text] [Related]
5. [Clinical significance of anti-centromere antibody and anti-CENP-B antibody in sera of patients with primary biliary cirrhosis].
Onozuka Y; Shibata M; Yonezawa H; Terauti K; Miyachi K; Ueno Y
Rinsho Byori; 1996 Sep; 44(9):877-82. PubMed ID: 8911074
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic accuracy of atypical p-ANCA in autoimmune hepatitis using ROC- and multivariate regression analysis.
Terjung B; Bogsch F; Klein R; Söhne J; Reichel C; Wasmuth JC; Beuers U; Sauerbruch T; Spengler U
Eur J Med Res; 2004 Sep; 9(9):439-48. PubMed ID: 15546809
[TBL] [Abstract][Full Text] [Related]
7. Detection of M2 antimitochondrial antibodies by dot blot assay is more specific than by enzyme linked immunosorbent assay.
Bargou I; Mankaï A; Jamaa A; Ben Jazia I; Skandrani K; Sfar H; Baccouche A; Ajmi S; Letaief A; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2008 Feb; 56(1):10-4. PubMed ID: 17604571
[TBL] [Abstract][Full Text] [Related]
8. Tissue transglutaminase antibodies in celiac disease, comparison of an enzyme linked immunosorbent assay and a dot blot assay.
Mankaï A; Sakly W; Landolsi H; Gueddah L; Sriha B; Ayadi A; Sfar MT; Skandrani K; Harbi A; Essoussi AS; Korbi S; Fabien N; Jeddi M; Ghedira I
Pathol Biol (Paris); 2005 May; 53(4):204-9. PubMed ID: 15850953
[TBL] [Abstract][Full Text] [Related]
9. Clinical and serological heterogeneity in patients with anticentromere antibodies.
Miyawaki S; Asanuma H; Nishiyama S; Yoshinaga Y
J Rheumatol; 2005 Aug; 32(8):1488-94. PubMed ID: 16078324
[TBL] [Abstract][Full Text] [Related]
10. [Anti-Jo-1 autoantibodies (anti-histidyl tRNA synthetase autoantibodies)].
Hirakata M; Mimori T
Nihon Rinsho; 1999 Nov; 57 Suppl():431-4. PubMed ID: 10635875
[No Abstract] [Full Text] [Related]
11. [Immunologic tests: Anti-polymyositis-scleroderma (PM-Scl) antibody].
Takasaki Y
Nihon Rinsho; 2005 Jul; 63 Suppl 7():502-4. PubMed ID: 16111314
[No Abstract] [Full Text] [Related]
12. [Antihistones antibodies in systemic lupus erythematosus, comparison of three assays: Elisa, dot blot and immunoblot].
Ghedira I; Landolsi H; Mankai A; Fabien N; Jeddi M
Pathol Biol (Paris); 2006 Apr; 54(3):148-54. PubMed ID: 16169158
[TBL] [Abstract][Full Text] [Related]
13. [The positive rate of auto antibodies and autoimmune liver diseases in patients with abnormal liver function].
Liu YM; Yan HP; Wang JT
Zhonghua Gan Zang Bing Za Zhi; 2004 Jun; 12(6):360-2. PubMed ID: 15225434
[TBL] [Abstract][Full Text] [Related]
14. [Cloning and prokaryotic expression of recombinant Jo-1 antigen and identification of its antigen specificity].
Zhao XY; Bi ZL; Wu YH; Xin HT
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2008 Dec; 24(12):1170-3. PubMed ID: 19068203
[TBL] [Abstract][Full Text] [Related]
15. Differences in anti-LKM-1 autoantibody immunoreactivity to CYP2D6 antigenic sites between hepatitis C virus-negative and -positive patients.
Kitazawa E; Igarashi T; Kawaguchi N; Matsushima H; Kawashima Y; Hankins RW; Miyakawa H
J Autoimmun; 2001 Nov; 17(3):243-9. PubMed ID: 11712862
[TBL] [Abstract][Full Text] [Related]
16. Anti-LC1 autoantibodies in patients with chronic hepatitis C virus infection.
Béland K; Lapierre P; Marceau G; Alvarez F
J Autoimmun; 2004 Mar; 22(2):159-66. PubMed ID: 14987745
[TBL] [Abstract][Full Text] [Related]
17. Autoantibodies and their antigens in autoimmune hepatitis.
Bogdanos DP; Mieli-Vergani G; Vergani D
Semin Liver Dis; 2009 Aug; 29(3):241-53. PubMed ID: 19675997
[TBL] [Abstract][Full Text] [Related]
18. Hepatitis C virus infection associated with liver-kidney microsomal antibody type 1 (LKM1) autoantibodies in children.
Bortolotti F; Muratori L; Jara P; Hierro L; Verucchi G; Giacchino R; Barbera C; Zancan L; Guido M; Resti M; Pedditzi S; Bianchi F; Gatta A
J Pediatr; 2003 Feb; 142(2):185-90. PubMed ID: 12584542
[TBL] [Abstract][Full Text] [Related]
19. [Immunologic tests: Anti-Jo-l antibody (anti-histidyl transfer RNA synthetase antibody)].
Katsuki Y; Hirakata M
Nihon Rinsho; 2005 Jul; 63 Suppl 7():505-7. PubMed ID: 16111315
[No Abstract] [Full Text] [Related]
20. Novel aspects of autoantibodies to the PM/Scl complex: clinical, genetic and diagnostic insights.
Mahler M; Raijmakers R
Autoimmun Rev; 2007 Aug; 6(7):432-7. PubMed ID: 17643929
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
